- Home
- AVPT vs EWTX Comparison
AVPT vs EWTX Comparison
Compare AVPT & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVPT
- EWTX
- Stock Information
- Founded
- AVPT 2001
- EWTX 2017
- Country
- AVPT United States
- EWTX United States
- Employees
- AVPT N/A
- EWTX N/A
- Industry
- AVPT Computer Software: Prepackaged Software
- EWTX Biotechnology: Pharmaceutical Preparations
- Sector
- AVPT Technology
- EWTX Health Care
- Exchange
- AVPT Nasdaq
- EWTX Nasdaq
- Market Cap
- AVPT 3.2B
- EWTX 2.6B
- IPO Year
- AVPT N/A
- EWTX 2021
- Fundamental
- Price
- AVPT $17.21
- EWTX $26.26
- Analyst Decision
- AVPT Buy
- EWTX Buy
- Analyst Count
- AVPT 5
- EWTX 6
- Target Price
- AVPT $15.00
- EWTX $44.83
- AVG Volume (30 Days)
- AVPT 1.2M
- EWTX 872.6K
- Earning Date
- AVPT 02-27-2025
- EWTX 02-20-2025
- Dividend Yield
- AVPT N/A
- EWTX N/A
- EPS Growth
- AVPT N/A
- EWTX N/A
- EPS
- AVPT N/A
- EWTX N/A
- Revenue
- AVPT $315,923,000.00
- EWTX N/A
- Revenue This Year
- AVPT $23.58
- EWTX N/A
- Revenue Next Year
- AVPT $18.29
- EWTX N/A
- P/E Ratio
- AVPT N/A
- EWTX N/A
- Revenue Growth
- AVPT 21.13
- EWTX N/A
- 52 Week Low
- AVPT $7.08
- EWTX $11.91
- 52 Week High
- AVPT $19.16
- EWTX $38.12
- Technical
- Relative Strength Index (RSI)
- AVPT 51.90
- EWTX 42.66
- Support Level
- AVPT $15.70
- EWTX $23.08
- Resistance Level
- AVPT $17.24
- EWTX $30.30
- Average True Range (ATR)
- AVPT 0.53
- EWTX 1.70
- MACD
- AVPT 0.01
- EWTX 0.11
- Stochastic Oscillator
- AVPT 72.60
- EWTX 44.04
About AVPT AvePoint Inc.
AvePoint Inc provides customizable solutions to optimize SaaS operations, enable secure collaboration, and accelerate digital transformation across technologies and industries. Its Confidence Platform delivers a comprehensive set of cloud-based solutions enabling IT operations, development operations, and cybersecurity professionals to monitor and secure the digital workplace using SaaS tools.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.